S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.03%) $0.926
USD/NOK
(-0.09%) $10.83
USD/GBP
(-0.10%) $0.791
USD/RUB
(-0.21%) $92.38

Realtime updates for Galectin Therapeutics Inc [GALT]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 16:00

-0.83% $ 2.39

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases...

Stats
Today's Volume 56 955.00
Average Volume 73 414.00
Market Cap 147.82M
EPS $-0.240 ( 2023-11-13 )
Next earnings date ( $-0.160 ) 2024-04-04
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -3.14
ATR14 $0.0100 (0.42%)
Insider Trading
Date Person Action Amount type
2024-03-01 Lewis Joel Sell 152 584 Common Stock
2023-12-07 Carson Benjamin Sr Sell 100 000 Common Stock Options
2024-01-24 Zordani Richard A. Jr. Buy 50 000 Stock Option (right to buy)
2024-01-24 Uihlein Richard E Buy 23 256 Common Stock
2024-01-24 Uihlein Richard E Buy 50 000 Stock Option (right to buy)
INSIDER POWER
24.86
Last 98 transactions
Buy: 4 274 677 | Sell: 2 394 317

Volume Correlation

Long: 0.06 (neutral)
Short: -0.41 (neutral)
Signal:(50.768) Neutral

Galectin Therapeutics Inc Correlation

10 Most Positive Correlations
BRACU0.946
KIN0.945
ALGM0.929
ACVA0.929
NCAC0.925
CLBT0.921
PEGA0.92
NSIT0.92
AMYT0.919
SRRA0.919
10 Most Negative Correlations
DCRC-0.928
AHPI-0.923
IMV-0.922
NCBS-0.921
TENX-0.92
LAWS-0.919
CFMS-0.919
TSHA-0.918
VWE-0.917
SGLB-0.914

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Galectin Therapeutics Inc Correlation - Currency/Commodity

The country flag -0.50
( neutral )
The country flag -0.38
( neutral )
The country flag 0.00
( neutral )
The country flag -0.62
( weak negative )
The country flag 0.00
( neutral )
The country flag 0.41
( neutral )

Galectin Therapeutics Inc Financials

Annual 2022
Revenue: $0
Gross Profit: $-32 000.00 (0.00 %)
EPS: $-0.660
Q3 2023
Revenue: $0
Gross Profit: $-8 000.00 (0.00 %)
EPS: $-0.170
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.150
Q1 2023
Revenue: $0
Gross Profit: $-32 000.00 (0.00 %)
EPS: $-0.210

Financial Reports:

No articles found.

Galectin Therapeutics Inc

Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial for the treatment of liver fibrosis associated with fatty liver disease and non-alcoholic steatohepatitis cirrhosis, as well as for the treatment of cancer. It also engages in developing GM-CT-01, which is in pre-clinical development stage for the treatment of cardiac and vascular fibrosis, as well as focuses on developing belapectin for the treatment of psoriasis, and lung and kidney fibrosis. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and development of small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators